Home › Lupus
Pag-aaral pangklinika para sa Lupus na nagre-recruit sa U.S.
74 pag-aaral para sa Lupus ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- New York City, NY18 pag-aaral
- Houston, TX14 pag-aaral
- Durham, NC12 pag-aaral
- Washington, DC11 pag-aaral
- Miami, FL10 pag-aaral
- Oklahoma City, OK9 pag-aaral
- San Diego, CA8 pag-aaral
- Tampa, FL8 pag-aaral
- Boston, MA8 pag-aaral
- Chicago, IL8 pag-aaral
- Philadelphia, PA8 pag-aaral
- Santa Monica, CA7 pag-aaral
- Plantation, FL7 pag-aaral
- Clearwater, FL7 pag-aaral
- Charlotte, NC7 pag-aaral
- Buena Park, CA7 pag-aaral
- Atlanta, GA7 pag-aaral
- Los Angeles, CA7 pag-aaral
- Memphis, TN6 pag-aaral
- Cedar Rapids, IA6 pag-aaral
- Dallas, TX6 pag-aaral
- Hollywood, FL5 pag-aaral
- Jackson, TN5 pag-aaral
- Lake Charles, LA5 pag-aaral
- St. Louis, MO5 pag-aaral
- New Rochelle, NY5 pag-aaral
- Cicero, IL5 pag-aaral
- Syracuse, NY5 pag-aaral
- Orlando, FL5 pag-aaral
- Mesquite, TX4 pag-aaral
- Frisco, TX4 pag-aaral
- Fullerton, CA4 pag-aaral
- New Orleans, LA4 pag-aaral
- Charleston, SC4 pag-aaral
- Kansas City, KS4 pag-aaral
- Louisville, KY4 pag-aaral
- Phoenix, AZ4 pag-aaral
- San Antonio, TX4 pag-aaral
- Coral Springs, FL4 pag-aaral
- El Paso, TX4 pag-aaral
Ayos sa estado
- Alabama5 pag-aaral
- Arizona7 pag-aaral
- California26 pag-aaral
- Colorado6 pag-aaral
- District of Columbia5 pag-aaral
- Florida23 pag-aaral
- Georgia9 pag-aaral
- Illinois14 pag-aaral
- Indiana3 pag-aaral
- Iowa6 pag-aaral
- Kansas4 pag-aaral
- Kentucky4 pag-aaral
- Louisiana8 pag-aaral
- Maryland11 pag-aaral
- Massachusetts9 pag-aaral
- Michigan10 pag-aaral
- Minnesota5 pag-aaral
- Missouri7 pag-aaral
- Montana3 pag-aaral
- Nebraska3 pag-aaral
- New Jersey6 pag-aaral
- New York25 pag-aaral
- North Carolina20 pag-aaral
- Ohio9 pag-aaral
- Oklahoma9 pag-aaral
- Pennsylvania13 pag-aaral
- South Carolina5 pag-aaral
- Tennessee12 pag-aaral
- Texas24 pag-aaral
- Utah4 pag-aaral
- Virginia3 pag-aaral
- Washington5 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
Nagre-recruitPhase 3
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07430306A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
Nagre-recruitPhase 2
Edad 18 hanggang 74 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07409181Pain Phenotyping of Rheumatic Diseases - An Observational Study
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 9 hanggang 85 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07829497Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT04751396Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT03816345Study of Afimetoran in Adults With Cutaneous Lupus Erythematosus
Nagre-recruitPhase 2/3
Edad 16 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07881120A Long-Term Extension (LTE) Study Of Enpatoran In Cutaneous Manifestations Of Lupus With Or Without Systemic Disease [Elowen-LTE]
Nagre-recruitPhase 3
Edad 18 hanggang 76 · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07840287Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 120 · Kababaihan · Na-update Nob 10, 2026 · NCT05567198Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
Nagre-recruitPhase 3
Edad 12 hanggang 100 · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT06133972Electroencephalogram Recording in Patients With Systemic Lupus Erythematosus
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 65 · Kababaihan · Na-update Nob 6, 2026 · NCT06378736A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07355218A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07332481A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07438496Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT06434363A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
Nagre-recruitObservasyonal na pag-aaral
Edad 16 pataas · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT07175285A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Nagre-recruitPhase 1
Edad 18 hanggang 74 · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT07085104A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Nagre-recruitPhase 3
Edad 16 pataas · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT06617325Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)
Nagre-recruitPhase 2
Edad 12 hanggang 65 · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT07053800Study of Systemic Lupus Erythematosus
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 3 hanggang 120 · Lahat ng kasarian · Na-update Okt 29, 2026 · NCT00001372Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
Nagre-recruitPhase 1
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT07201558Safety of the Herpes Zoster Subunit Vaccine in Lupus
Nagre-recruitPhase 4
Edad 18 hanggang 90 · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT05559671Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
Nagre-recruitPhase 1
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Okt 27, 2026 · NCT06975787A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
Nagre-recruitPhase 1
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT06925542A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
Nagre-recruitPhase 1
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT06613360A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
Nagre-recruitPhase 1
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 20, 2026 · NCT07607964Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.